Waters first-quarter sales increases 10% to $368 million

NewsGuard 100/100 Score

Waters Corporation (NYSE/WAT) reported first quarter 2010 sales of $368 million, an increase of 10% from sales of $333 million in the first quarter of 2009. In the quarter, foreign currency translation increased sales growth rate by 4% and, on a currency neutral basis, sales increased by 6% in comparison to the prior year's first quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the first quarter of 2010 were $0.79, compared to $0.75 for the first quarter of 2009. On a non-GAAP basis, including the adjustments in the attached reconciliation, E.P.S. grew 9% to $0.81 from $0.74 in the first quarter of 2009.

Commenting on the Company's performance, Douglas Berthiaume, Chairman, President and Chief Executive Officer said, "Strong demand for our new products and improving end-markets contributed to our sales growth in the first quarter. Shipments of our new instrument systems, including the Synapt™ G-2 and ACQUITY UPLC® H-Class, ramped up nicely in the quarter while our TA Instruments sales returned to growth based on strong product positions and improving demand from industrial chemical customers."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation